A rheumatological catastrophe: case of amyopathic juvenile dermatomyositis

Authors

  • Meghashree Vinod Department of Pediatrics, Mysore Medical College and Research Institute, Mysore, Karnataka, India
  • Nikitha K. Department of Pediatrics, Mysore Medical College and Research Institute, Mysore, Karnataka, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20241381

Keywords:

Amyopathic juvenile dermatomyositis, Anti-melanoma differentiation associated gene-5, Gottron’s papules

Abstract

Juvenile-onset amyopathic dermatomyositis is rare variant of juvenile-onset dermatomyositis (JDM), characterized by the hallmark cutaneous features of dermatomyositis without clinical or laboratory evidence of muscle disease. Dermatomyositis with positive anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody has a distinct phenotype associated with small hand joint arthritis, mucocutaneous ulceration in the absence of muscle involvement. In this article, we describe a 5-year-old child presented with mucocutaneous manifestations with no muscle weakness who responded to immunosuppressive therapy.

References

Kurtzman DJB, Vleugels RA. Anti-melanoma differentiation–associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol. 2010;78(4):776-85.

Walling HW, Gerami P, Sontheimer RD. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management. Paediatr Drugs. 2010;12(1):23-34.

Nombel A, Fabien N, Coutant F. Dermatomyositis with Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies. Front Immunol. 2021;12:773352.

Allenbach Y, Uzunhan Y, Toquet S, Leroux G, Gallay L, Marquet A, et al. Different Phenotypes in Dermatomyositis Associated with Anti-MDA5 Antibody: Study of 121 Cases. Neurology. 2020;95:e70-8.

Cao H, Pan M, Kang Y, Xia Q, Li X, Zhao X, et al. Clinical Manifestations of Dermatomyositis and Clinically Amyopathic Dermatomyositis Patients with Positive Expression of Anti-Melanoma Differentiation-Associated Gene 5 Antibody. Arthritis Care Res. 2012;64:1602-10.

Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The Mucocutaneous and Systemic Phenotype of Dermatomyositis Patients With Antibodies to MDA5 (CADM-140). J Am Acad Dermatol. 2011;65:25-34.

Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis. Arthritis Care Res. 2016;68(5):689-94.

Romero-Bueno F, Diaz del Campo P, Trallero-Araguás E, Ruiz-Rodríguez JC, Castellvi I, Rodriguez-Nieto MJ, et al. Recommendations for the Treatment of Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. Semin Arthritis Rheum. 2020;50:776-90.

Downloads

Published

2024-05-27

Issue

Section

Case Reports